financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Strong Sell Opinion On Shares Of Cintas Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Strong Sell Opinion On Shares Of Cintas Corporation
May 1, 2024 6:29 AM

09:05 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target to $620 from $550, 38.4x our FY 25 (May) EPS outlook (adjusted to $16.15 from $16.37; we lift FY 24's estimate to $14.90 from $14.65), above the company's five-year forward P/E multiple average. A beat on earnings and raised guidance is driving today's positive movement in share price. CTAS posted Feb-Q EPS of $3.84 vs. $3.18 (+22% Y/Y), $0.26 above consensus. Feb-Q sales were roughly in line with expectations, up 10% Y/Y (an increase of 8% on an organic basis). Margin performance drove earnings expansion during the quarter, with operating income margin widening by 120 bps to 21.6%. Profitability benefited from volume growth, technology improvements, and gains from investment into operational efficiencies. Investment into route optimization and plant equipment utilization are bearing fruit. Despite the solid quarter and our positive view of CTAS's execution on margins and sales expansion, we view valuation as extended, with a forward P/E of 40x at nearly double that of the S&P 500.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Humana Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Humana Inc.
Apr 2, 2024
12:30 AM EDT, 04/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $326, cut $54, reflects a 14x multiple on our revised '25 EPS estimate. The applied multiple is below HUM's historical forward average, but merited in...
Best total stock market index funds
Best total stock market index funds
Apr 3, 2024
Index funds have gained enormous popularity with investors over the past few decades as a cost-effective way to gain access to highly diversified portfolios. Through mutual funds and ETFs, total market index funds allow investors to purchase a basket of stocks that track an index focused on the overall U.S. stock market or markets around the world. They can be...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Intel Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Intel Corporation
Apr 2, 2024
12:35 AM EDT, 04/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: INTC announces a new reporting structure that separates its foundry business (its manufacturing arm), offering greater transparency to help build trust with external partners. Restated financials show foundry revenue of...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Teva Pharmaceutical Industries Ltd.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Teva Pharmaceutical Industries Ltd.
Apr 2, 2024
12:45 AM EDT, 04/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price by $2 to $14, reflecting 5.8x our 2024 EPS forecast. This is higher than its 5-year historical forward average of 3.9x as we expect the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved